Accenture Prescribes A New Data Management Future For Medtechs

The Last Mile Is The Longest – And The Best

The value of revenue streams derived from new business models is increasingly defined by how well companies manage the data within their ecosystems. Managing the data in the "last mile" subset provides an opportunity for medtech companies to generate income in that revenue stream, says Maximilian Schmid, head of the Global MedTech Practice at Accenture Life Sciences. 

IV1811_Accenture_87538264_1200.jpg
AI and machine learning could be both opportunities and threats to the medtech industry • Source: Shutterstock

The life sciences industry is changing fast, and manufacturers of health technology solutions are now rapidly facing a choice: adapt to changing demand and factor in the growing opportunity – or threat – that AI, machine learning and disruptive new entrants represent to the medtech field; or lose competitive positioning in the market.

Business services and strategic consulting group Accenture Life Sciences paints a picture of this evolving health care landscape in its...

More from Leadership

More from In Vivo